Form D · Biotechnology
Evolve Biosystems, Inc.
Davis, CA · CIK 0001651891
Offering snapshot reported Aug 27, 2015 · SEC filing
- Reported sold
- $9M Offering amount: $9M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 20, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 27, 2015 | Initial | $8,999,996 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-246552
Source: Form D, filed Aug 27, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Simon Barnes | Director |
| John Campbell | Executive |
| James Campbell | Executive |
| J. Bruce German | Director |
| Daniel Janney | Director |
| David J. Kyle | Director, Executive |
| Anne Lo | Director |
| Catherine Mackey | Director |
| David Mills | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2121 2 Nd Street, Suite B107
Davis, CA, 95618
Davis, CA, 95618